(Q45382919)

14 December 2017

Effect of hepatitis C virus and its treatment on survival (English)

1 reference

14 December 2017

1 reference

1 reference

3

1 reference

14 December 2017

Adeel A Butt

1

1 reference

PubMed ID

19591128

14 December 2017

Xiaoqiang Wang

series ordinal

2

1 reference

PubMed ID

19591128

14 December 2017

language of work or name

English

0 references

publication date

1 August 2009

1 reference

14 December 2017

1 reference

14 December 2017

50

1 reference

14 December 2017

2

1 reference

14 December 2017

387-392

1 reference

Hepatitis C virus infection: the new global epidemic

14 December 2017

1 reference

Hepatocellular carcinoma: recent trends in the United States

21 January 2018

1 reference

Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a meta-analysis

21 January 2018

1 reference

Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors

21 January 2018

1 reference

Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective study.

21 January 2018

1 reference

45-year follow-up of hepatitis C virus infection in healthy young adults

21 January 2018

1 reference

Clinical course of hepatitis C virus during the first decade of infection: cohort study

21 January 2018

1 reference

HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis.

21 January 2018

1 reference

Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival

21 January 2018

1 reference

The association between hepatitis C infection and survival after orthotopic liver transplantation

21 January 2018

1 reference

Risk of death and liver cirrhosis in anti-HCV-positive long-term haemodialysis patients

21 January 2018

1 reference

Cost-effectiveness of treatment for hepatitis C in an urban cohort co-infected with HIV.

21 January 2018

1 reference

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

Peginterferon alfa-2a in patients with chronic hepatitis C.

21 January 2018

1 reference

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

21 January 2018

1 reference

Rate and predictors of treatment prescription for hepatitis C.

21 January 2018

1 reference

Rates and predictors of hepatitis C virus treatment in HCV-HIV-coinfected subjects

21 January 2018

1 reference

Comorbidities and their impact on mortality in HCV and HCV-HIV-coinfected persons on dialysis

21 January 2018

1 reference

Limited success of HCV antiviral therapy in United States veterans

21 January 2018

1 reference

Spectrum of disease in U.S. veteran patients with hepatitis C.

21 January 2018

1 reference

Epidemiology of hepatitis C virus infection in American veterans

21 January 2018

1 reference

Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.23000

1 reference

14 December 2017

1 reference

PubMed ID

19591128